Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

P. Barton Duell

Professor of Medicine

Oregon Health & Science University

United States

Research Interests

Explore related searches

Professors in United States

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Collaborators (9)

Dirk Blom

University of Cape Town

SOUTH AFRICA

View details

Maya Safarova

Cardiologist

Medical College of Wisconsin

UNITED STATES

View details

John Bucheit

Associate Professor

Virginia Commonwealth University School of Pharmacy

UNITED STATES

View details

Ulrich Laufs

Leipzig University

GERMANY

View details

Zahid Ahmad

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES

View details

Ron Newfield

Clincal Professor of Pediatrics

University of California, San Diego

UNITED STATES

View details

Marina Cuchel

University of Pennsylvania

UNITED STATES

View details

Bruce Warden

Oregon Health & Science University

UNITED STATES

View details

Erin Michos

Associate Professor of Medicine and Epidemiology

Johns Hopkins University School of Medicine

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

P. Barton Duell

Research Interests

Explore related searches

Articles (20)

Pharmacotherapy for obesity management—Emphasizing the role of GLP-1 receptor agonist-based therapeutics

Real-world evaluation of bempedoic acid use in patients with homozygous familial hypercholesterolemia

Efficacy and Safety of Bempedoic Acid in Patients Aged ≥75 Years Stratified by Varying Statin Exposure: Results From Phase 3 Studies of Bempedoic Acid

Recognition and management of persistent chylomicronemia: A joint expert clinical consensus by the National Lipid Association and the American Society for Preventive Cardiology

Real-World Effectiveness and Safety of Evinacumab in Children and Adults With Homozygous Familial Hypercholesterolemia: A Multisite US Perspective—Brief Report

Long-term experience with lomitapide treatment in patients with homozygous familial hypercholesterolemia: Over 10 years of efficacy and safety data

Lipoprotein X – Pathophysiology, diagnosis, and management

Statin Use in Special Populations for the Prevention of Cardiovascular Disease in Adults

Exciting new developments in clinical lipidology: Updates from the Food and Drug Administration and the American Heart Association

JCL roundtable: European perspective on comprehensive lipid management and cardiovascular health

Efficacy, safety, and tolerability of chenodeoxycholic acid (CDCA) in adult patients with cerebrotendinous xanthomatosis (RESTORE): A randomized withdrawal, double-blind, placebo-controlled, crossover phase-3 study

Oral semaglutide and reduction in major adverse cardiovascular events

Achilles tendon palpation for diagnosis of familial hypercholesterolemia: The compelling need to restore a valuable lost art

Helping clinicians interpret the evidence supporting dietary recommendations

Lipoprotein Apheresis: Utility, Outcomes, and Implementation in Clinical Practice: A Scientific Statement From the American Heart Association

From the editors: Upcoming treatments for familial chylomicronemia syndrome: Agents that inhibit production of apolipoprotein CIII

Does Adopting Western Low-density Lipoprotein Cholesterol Targets Expose Indians to a Higher Risk of Cardiovascular Events? Expert Opinion From the Lipid Association of India

NLA Expert Clinical Consensus on apolipoprotein B recommends expanded clinical use and improved patient access

Rapid achievement of low-density lipoprotein cholesterol goals within 1 month after acute coronary syndrome during combination therapy with rosuvastatin, ezetimibe and bempedoic acid: Initial experience from the LAI-REACT study

Disparities in access to pharmacotherapies for weight loss and cardiovascular prevention

Collaborators (9)

Dirk Blom

Maya Safarova

John Bucheit

Ulrich Laufs

Zahid Ahmad

Ron Newfield

Marina Cuchel

Bruce Warden

Erin Michos

Make your next move.